Nanomedicine Market
Nanomedicine Market Forecasts to 2030 - Global Analysis By Product Type (Nanoparticles, Nano Tubes, Nano Devices, Nano Shells and Other Product Types), Modality (Treatment and Diagnostics), Indication, Application and by Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $432.84 MN |
|
Projected Year Value (2030) |
US $1130.51 MN |
|
CAGR (2023 - 2030) |
14.7% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Nanomedicine Market is accounted for $432.84 million in 2023 and is expected to reach $1,130.51 million by 2030 growing at a CAGR of 14.7% during the forecast period. The innovative use of nanotechnology in healthcare is known as nanomedicine. It utilizes a material's properties at its nanometric scale of 10-9 m, which are frequently different from the same substance at a larger size in terms of biology, chemistry, and physics. Additionally, because many biological processes in the human body operate on a nanometric scale, nanomaterials and nanoparticles may be able to get past obstacles in the way of their intended delivery systems and interact at different degrees with small proteins or DNA in blood or within organs, cells, and tissues.
According to the Centres for Disease Control and Prevention, one in four fatalities in the United States occurred due to heart disease in 2021.
Market Dynamics:
Driver:
Growing chronic illness incidence
Advanced medical solutions are urgently needed as the burden of chronic diseases, such as diabetes, cancer, cardiovascular disease, and neurodegenerative disorders, is rising globally. Moreover, the potential of nanomedicine to provide targeted interventions, early disease detection, and more effective therapies is in line with the needs of an increasing number of patients suffering from these chronic illnesses.
Restraint:
High price of development
Due to the fact that these technologies are so complex, developing new products in the field of nanomedicine requires large financial outlays. Additionally, the design and testing of nanoscale drug delivery systems, diagnostic instruments, and nanoparticles are all part of the research and development process, which can be resource-intensive. For startups and smaller businesses, this high development cost may be a barrier to entry.
Opportunity:
Advances in drug administration
The ongoing advancement of drug delivery systems driven by nanomedicine presents prospects for optimizing the administration of medication. By lowering dosage frequency and offering controlled, sustained drug release, these innovations may enhance patient adherence and compliance. Furthermore, this improves patient satisfaction as well as the effectiveness of treatment, especially when managing chronic diseases.
Threat:
Social and ethical issues
Public acceptance and perception of nanotechnology in medicine may be impacted by ethical worries about data security, privacy, and possible misuse of nanoscale devices. Moreover, gaining the public's trust and overcoming resistance to nanomedicine require addressing these ethical issues and making sure that development is done responsibly.
Covid-19 Impact:
The market for nanomedicine has been impacted by the COVID-19 pandemic in a number of ways. The pandemic emphasized the need for cutting-edge medical procedures, therapies, and vaccinations, but it also caused supply chain disruptions, postponed research initiatives, and redirected funds toward pandemic response efforts. Positively, new drug delivery methods, COVID-19 vaccines at the nanoscale, and diagnostics were all made possible by nanomedicine. However, some nanomedicine initiatives faced funding difficulties as a result of the pandemic's economic effects, especially in the academic and research sectors.
The Cardiovascular Diseases segment is expected to be the largest during the forecast period
Cardiovascular diseases are predicted to hold the largest share in the market. Heart and blood vessel disorders, including coronary artery disease, hypertension, congestive heart failure, and arrhythmias, are all considered cardiovascular diseases. The high prevalence of cardiovascular diseases worldwide and their substantial impact on public health are the reasons for this segment's prominence. Moreover, pharmaceuticals, medical devices, diagnostic tools, and interventional procedures are all part of the cardiovascular disease market. The development of novel therapies, cardiac surgery advancements, and interventional cardiology has all been major factors in this market's expansion.
The Regenerative Medicine segment is expected to have the highest CAGR during the forecast period
The regenerative medicine segment holds the highest CAGR in the market. Developing treatments and methods to replace, regenerate, or repair diseased or damaged tissues and organs is known as regenerative medicine. It includes the use of biomaterials to support natural healing processes, tissue engineering, and stem cell therapies. Furthermore, the aging population, the rise in chronic illness, and the demand for novel treatments capable of curing a broad spectrum of illnesses, from neurological disorders to cardiovascular diseases, are the main causes of the high compound annual growth rate.
Region with largest share:
Due to a number of factors, including a well-established healthcare infrastructure, high healthcare expenditures, robust research and development activities, and an aging population with greater healthcare needs, North America is predicted to hold the largest share of the global healthcare market. Moreover, the region is a major player in the healthcare sector because of its cutting-edge medical technologies, pharmaceutical companies, top research institutions, and strong emphasis on innovation. With the United States and Canada at the forefront of medical advancements and healthcare services, North America's proactive response to emerging healthcare challenges and diseases further solidifies its position as a leader in the global healthcare market.
Region with highest CAGR:
In the global healthcare market, the Asia-Pacific region has the highest CAGR. Numerous factors, such as the region's expanding population, growing awareness of healthcare, accelerating economic development, and improved access to healthcare services, are driving this amazing growth. Additionally, the Asia-Pacific area has drawn large investments from pharmaceutical firms and suppliers of medical technology, making it a hub for clinical trials, medical research, and development. Consequently, the region is experiencing swift progress in healthcare infrastructure, novel therapies, and digital health solutions, thereby establishing itself as a primary catalyst for growth and innovation in the global healthcare industry.
Key players in the market
Some of the key players in Nanomedicine market include NanoCarrier Co. Ltd, Sanofi SA, Leadient BioSciences Inc., Sigma-Tau Pharmaceuticals, Inc., Celgene Corporation, Abbott Laboratories, CombiMatrix Corporation, Johnson & Johnson Services Inc, Mallinckrodt Pharmaceuticals, Nanobiotix, Merck & Co., Inc., Nanospectra Biosciences, Inc., Gilead Sciences, Inc., Arrowhead Pharmaceuticals, Inc., Novavax, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., GE Healthcare, Taiwan Liposome Company Ltd and Genzyme Corporation.
Key Developments:
In October 2023, Janssen Pharmaceuticals, Inc., a Johnson & Johnson Company, announced a development and commercialization agreement with Sanofi for Janssen’s extraintestinal pathogenic Escherichia coli (ExPEC) investigational vaccine program. The lead vaccine candidate is currently being evaluated in the Phase 3 E.mbrace study for the prevention of invasive E. coli disease (IED) in adults aged 60 years and older.
In October 2023, Sanofi announces that it has entered into an agreement with Janssen Pharmaceuticals, Inc. (Janssen), a Johnson & Johnson company, to develop and commercialize the vaccine candidate for extraintestinal pathogenic E. coli (9-valent) developed by Janssen, currently in Phase 3. The agreement brings together Janssen’s robust science behind this potential first-in-class product and Sanofi’s worldwide manufacturing footprint and recognized world-class expertise in launching innovative vaccines.
In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a smart insulin management system. It features connected insulin pen caps that use integrated continuous glucose monitoring (iCGM) data and healthcare provider instructions.
Product Types Covered:
• Nanoparticles
• Nano Tubes
• Nano Devices
• Nano Shells
• Other Product Types
Modalities Covered:
• Treatment
• Diagnostics
Indications Covered:
• Clinical Oncology
• Infectious Diseases
• Clinical Cardiology
• Urology
• Ophthalmology
• Immunology
• Cardiovascular Diseases
• Orthopedic Diseases
• Neurological Diseases
• Anti-Inflammatory Diseases
• Anti-Infective Diseases
• Other Indications
Applications Covered:
• Drug Delivery
• Diagnostic Imaging
• In vitro Diagnostics
• Implants
• Regenerative Medicine
• Vaccines
• In-Vitro Imaging
• Therapeutics
• In-vivo Imaging
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nanomedicine Market, By Product Type
5.1 Introduction
5.2 Nanoparticles
5.2.1 Metal & Metal Oxide Nanoparticles
5.2.2 Liposomes
5.2.3 Polymers & Polymer Drug Conjugates
5.2.4 Hydrogel Nanoparticles
5.2.5 Dendrimers
5.2.6 Inorganic Nanoparticles
5.3 Nano Tubes
5.4 Nano Devices
5.5 Nano Shells
5.6 Other Product Types
6 Global Nanomedicine Market, By Modality
6.1 Introduction
6.2 Treatment
6.3 Diagnostics
7 Global Nanomedicine Market, By Indication
7.1 Introduction
7.2 Clinical Oncology
7.3 Infectious Diseases
7.4 Clinical Cardiology
7.5 Urology
7.6 Ophthalmology
7.7 Immunology
7.8 Cardiovascular Diseases
7.9 Orthopedic Diseases
7.10 Neurological Diseases
7.11 Anti-Inflammatory Diseases
7.12 Anti-Infective Diseases
7.13 Other Indications
8 Global Nanomedicine Market, By Application
8.1 Introduction
8.2 Drug Delivery
8.3 Diagnostic Imaging
8.4 In vitro Diagnostics
8.5 Implants
8.6 Regenerative Medicine
8.7 Vaccines
8.8 In-Vitro Imaging
8.9 Therapeutics
8.10 In-vivo Imaging
8.11 Other Applications
9 Global Nanomedicine Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 NanoCarrier Co. Ltd
11.2 Sanofi SA
11.3 Leadient BioSciences Inc.
11.4 Celgene Corporation
11.5 Abbott Laboratories
11.6 CombiMatrix Corporation
11.7 Johnson & Johnson Services Inc
11.8 Mallinckrodt Pharmaceuticals
11.9 Nanobiotix
11.10 Merck & Co., Inc.
11.11 Nanospectra Biosciences, Inc.
11.12 Gilead Sciences, Inc.
11.13 Arrowhead Pharmaceuticals, Inc.
11.14 Novavax, Inc.
11.15 Pfizer, Inc.
11.16 Teva Pharmaceutical Industries Ltd.
11.17 GE Healthcare
11.18 Taiwan Liposome Company Ltd
11.19 Genzyme Corporation
List of Tables
1 Global Nanomedicine Market Outlook, By Region (2021-2030) ($MN)
2 Global Nanomedicine Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Nanomedicine Market Outlook, By Nanoparticles (2021-2030) ($MN)
4 Global Nanomedicine Market Outlook, By Metal & Metal Oxide Nanoparticles (2021-2030) ($MN)
5 Global Nanomedicine Market Outlook, By Liposomes (2021-2030) ($MN)
6 Global Nanomedicine Market Outlook, By Polymers & Polymer Drug Conjugates (2021-2030) ($MN)
7 Global Nanomedicine Market Outlook, By Hydrogel Nanoparticles (2021-2030) ($MN)
8 Global Nanomedicine Market Outlook, By Dendrimers (2021-2030) ($MN)
9 Global Nanomedicine Market Outlook, By Inorganic Nanoparticles (2021-2030) ($MN)
10 Global Nanomedicine Market Outlook, By Nano Tubes (2021-2030) ($MN)
11 Global Nanomedicine Market Outlook, By Nano Devices (2021-2030) ($MN)
12 Global Nanomedicine Market Outlook, By Nano Shells (2021-2030) ($MN)
13 Global Nanomedicine Market Outlook, By Other Product Types (2021-2030) ($MN)
14 Global Nanomedicine Market Outlook, By Modality (2021-2030) ($MN)
15 Global Nanomedicine Market Outlook, By Treatment (2021-2030) ($MN)
16 Global Nanomedicine Market Outlook, By Diagnostics (2021-2030) ($MN)
17 Global Nanomedicine Market Outlook, By Indication (2021-2030) ($MN)
18 Global Nanomedicine Market Outlook, By Clinical Oncology (2021-2030) ($MN)
19 Global Nanomedicine Market Outlook, By Infectious Diseases (2021-2030) ($MN)
20 Global Nanomedicine Market Outlook, By Clinical Cardiology (2021-2030) ($MN)
21 Global Nanomedicine Market Outlook, By Urology (2021-2030) ($MN)
22 Global Nanomedicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
23 Global Nanomedicine Market Outlook, By Immunology (2021-2030) ($MN)
24 Global Nanomedicine Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
25 Global Nanomedicine Market Outlook, By Orthopedic Diseases (2021-2030) ($MN)
26 Global Nanomedicine Market Outlook, By Neurological Diseases (2021-2030) ($MN)
27 Global Nanomedicine Market Outlook, By Anti-Inflammatory Diseases (2021-2030) ($MN)
28 Global Nanomedicine Market Outlook, By Anti-Infective Diseases (2021-2030) ($MN)
29 Global Nanomedicine Market Outlook, By Other Indications (2021-2030) ($MN)
30 Global Nanomedicine Market Outlook, By Application (2021-2030) ($MN)
31 Global Nanomedicine Market Outlook, By Drug Delivery (2021-2030) ($MN)
32 Global Nanomedicine Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
33 Global Nanomedicine Market Outlook, By In vitro Diagnostics (2021-2030) ($MN)
34 Global Nanomedicine Market Outlook, By Implants (2021-2030) ($MN)
35 Global Nanomedicine Market Outlook, By Regenerative Medicine (2021-2030) ($MN)
36 Global Nanomedicine Market Outlook, By Vaccines (2021-2030) ($MN)
37 Global Nanomedicine Market Outlook, By In-Vitro Imaging (2021-2030) ($MN)
38 Global Nanomedicine Market Outlook, By Therapeutics (2021-2030) ($MN)
39 Global Nanomedicine Market Outlook, By In-vivo Imaging (2021-2030) ($MN)
40 Global Nanomedicine Market Outlook, By Other Applications (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
